FDA Declines To Add 510(k)s To Pediatric Data Guidance, But Does Address De Novos
This article was originally published in The Gray Sheet
Industry has asked FDA to expand the scope of its guidance on extrapolating adult trial data to pediatric submissions to include 510(k)s. In a final guidance, FDA declined to do so, but it did expand the scope of the guidelines to include de novo applications.
You may also be interested in...
At a recent pediatric medical devices workshop at US FDA headquarters, the focus turned less to regulatory burdens and more to lacking reimbursement and financial incentives as barriers to bringing child-focused products to market.
In the final medical device electromagnetic compatibility guidance FDA clarified the scope of applications that could use this guidance and added a recommendation for sponsors to identify and consider the intended use environmental that could affect the EMC of their products.
The trade group says FDA's recent draft guidance on employing adult device data to help support a pediatric indication should be expanded to include 510(k)s, rather than being limited to PMAs and HDEs.